To discover, search, filter and sort thousands of companies, funding rounds and job listings you must sign in.
Employbl is a purpose crafted, comprehensive search engine for tech professionals.
Create Your Profile
Versanis Bio logo

Versanis Bio

Versanis Bio is advancing bimagrumab, a human monoclonal antibody to the activin type II receptors that blocks the binding of ligands including activin A and myostatin. Bimagrumab has been studied by Novartis in more than a dozen controlled clinical trials that enrolled more than 1,500 people. Across key studies bimagrumab treatment consistently and potently induced significant loss of fat mass without loss of lean mass, and additionally improved HbA1c and other cardiometabolic parameters.

versanisbio.com

Founded

2021

Employees

Between 2 - 10 employees

Raised

$70,000,000

Headquarters Location

1111 Broadway Suite 1300, Oakland, CA 94607

Public

FALSE

Acquired

FALSE

Founders

Mark Fishman
Mark Fishman
Joe Jimenez
Joe Jimenez

CEO

Lloyd Klickstein

Funding Rounds

$70,000,000

  • Aditum Bio
  • Atlas Venture
  • Medicxi

August 2021

Hmm no matching results. Please try a different search of login to the Employbl dashboard to use advanced search.

You can find more tech companies and startups, with financial and hiring information by creating a free account.
Get Started